PharmaShots | Incisive News in 3 Shots

Subscribe Now

Axial Spondyloarthritis Spectrum

UCB's Cimzia (certolizumab pegol) Receives the EMA's Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthritis Spectrum

UCB's Cimzia (certolizumab pegol) Receives the EMA's Approval for a Reduced Maintenance Dose in Patients with Axial Spondyloarthri...

August 6, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us